KCM
PTX

Kennedy Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Kennedy Capital Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-60,847
Closed -$1.92M – 775
2015
Q3 		$1.92M Sell
60,847
-18,727
-24% -$896K 0.04% 577
2015
Q2 		$4.71M Sell
79,574
-87,241
-52% -$6.15M 0.08% 411
2015
Q1 		$17.8M Buy
166,815
+3,490
+2% +$333K 0.31% 74
2014
Q4 		$15.3M Buy
163,325
+98,470
+152% +$9.39M 0.28% 84
2014
Q3 		$4.98M Buy
64,855
+31,616
+95% +$2.49M 0.1% 372
2014
Q2 		$2.98M Buy
+33,239
New +$2.04M 0.06% 471

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Kennedy Capital Management's PTX Position: Q4 2015 in Review

Kennedy Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2015, closing a stake of 60,847 shares — an estimated $1.92M sold.

Kennedy Capital Management first reported a position in PTX in Q2 2014 and held it in 6 quarters. The position peaked at $17.8M in Q1 2015. 101 funds tracked by Wall St. Rank hold PTX as of Q4 2015.

  • Kennedy Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2015 after selling out during the quarter.
  • Kennedy Capital Management sold 60,847 Pernix Therapeutics Holdings, Inc. shares in Q4 2015, an estimated $1.92M.
  • Kennedy Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 6 quarters.
  • Kennedy Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $17.8M in Q1 2015.
  • 101 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2015.

Based on Kennedy Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.